BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12097462)

  • 1. Invited commentary: one step forward.
    Lastoria S; Piccolo S; Muto P
    J Nucl Med; 2002 Jul; 43(7):916-7. PubMed ID: 12097462
    [No Abstract]   [Full Text] [Related]  

  • 2. Tc-99m sestamibi exam finds niche in breast Dx.
    Chen EM; Khalkhali I; Cutrone JA; Diggles LE; Mishkin F
    Diagn Imaging (San Franc); 1997 Aug; 19(8):61-5. PubMed ID: 10169379
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of patient positioning in scintimammography.
    Mirzaei S; Knoll P; Köhn H; Lipp RW; Zajicek SM
    Eur J Nucl Med; 2001 Sep; 28(9):1437-8. PubMed ID: 11585308
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast-specific gamma imaging for detection of breast cancer.
    Riordan W
    Radiology; 2009 Apr; 251(1):306; author reply 306. PubMed ID: 19332861
    [No Abstract]   [Full Text] [Related]  

  • 5. High-resolution scintimammography: a pilot study.
    Brem RF; Schoonjans JM; Kieper DA; Majewski S; Goodman S; Civelek C
    J Nucl Med; 2002 Jul; 43(7):909-15. PubMed ID: 12097461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast-specific gamma imaging (BSGI), molecular breast imaging (MBI), or scintimammography with breast-specific gamma camera.
    BlueCross BlueShield Association
    Technol Eval Cent Assess Program Exec Summ; 2013 Jun; 28(2):1-4. PubMed ID: 23865107
    [No Abstract]   [Full Text] [Related]  

  • 7. Procedure guideline for breast scintigraphy. Society of Nuclear Medicine.
    Khalkhali I; Diggles LE; Taillefer R; Vandestreek PR; Peller PJ; Abdel-Nabi HH
    J Nucl Med; 1999 Jul; 40(7):1233-5. PubMed ID: 10405150
    [No Abstract]   [Full Text] [Related]  

  • 8. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Mirzaei S; Knoll P; Lipp RW; Köhn H
    J Nucl Med; 2000 Feb; 41(2):390-1. PubMed ID: 10688127
    [No Abstract]   [Full Text] [Related]  

  • 9. Scintimammography in breast cancer diagnosis.
    Newman J
    Radiol Technol; 1998; 70(2):153-68; quiz 169-72. PubMed ID: 9839329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scintimammography: the new role of technetium-99m Sestamibi imaging for the diagnosis of breast carcinoma.
    Khalkhali I; Iraniha S; Diggles LE; Cutrone JA; Mishkin FS
    Q J Nucl Med; 1997 Sep; 41(3):231-8. PubMed ID: 9274131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
    Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast-specific gamma imaging in breast cancer].
    van Loevezijn AA; van Breda Vriesman AC; Neijenhuis PA; Pereira Arias-Bouda LM
    Ned Tijdschr Geneeskd; 2016; 160():A9610. PubMed ID: 26786798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.
    Chen S; Liu W; Mao Y; Zhu W; Yao Z; Sun X; Xiu Y; Yin Y; Chen J
    Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy.
    Maurer AH; Caroline DF; Jadali FJ; Manzone TA; Maier WP; Au FC; Schnall SF
    J Nucl Med; 1995 Sep; 36(9):1696-700. PubMed ID: 7658233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
    Delpassand ES; Jackson EF
    Radiology; 1997 Oct; 205(1):283-4; author reply 285-6. PubMed ID: 9315002
    [No Abstract]   [Full Text] [Related]  

  • 16. Technetium-99m sestamibi in the diagnosis of breast cancer. The Mayagüez Medical Center experience.
    Farías-Jimenez J; Rivera A; Carlo VM
    Bol Asoc Med P R; 2001; 93(1-12):9-11. PubMed ID: 12755069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific effects on uptake of 99mTc-sestamibi by breast lesions: a targeted analysis of false scintigraphic diagnoses.
    Tiling R; Stephan K; Sommer H; Shabani N; Linke R; Hahn K
    J Nucl Med; 2004 Nov; 45(11):1822-8. PubMed ID: 15534050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
    Villanueva-Meyer J; Leonard MH; Briscoe E; Cesani F; Ali SA; Rhoden S; Hove M; Cowan D
    J Nucl Med; 1996 Jun; 37(6):926-30. PubMed ID: 8683313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of patient positioning in scintimammography.
    Mirzaei S
    Eur J Nucl Med; 2001 Jul; 28(7):941-2. PubMed ID: 11504096
    [No Abstract]   [Full Text] [Related]  

  • 20. A perspective on decision analysis modeling as it relates to sestamibi imaging of nonpalpable breast abnormalities.
    Waxman AD
    J Nucl Med; 1997 Nov; 38(11):1778-80. PubMed ID: 9374353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.